🇺🇸 FluMist Quadrivalent (2017-2018) in United States

FluMist Quadrivalent (2017-2018) (FluMist Quadrivalent (2017-2018)) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

FluMist Quadrivalent (2017-2018) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is FluMist Quadrivalent (2017-2018) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for FluMist Quadrivalent (2017-2018) in United States?

MedImmune LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.